Figure 5From: Role and expression of FRS2 and FRS3 in prostate cancer Dual targeting of FRS2/FRS3 as an adjunct to radiotherapy. A and B: Percentage change in the number of colony forming units in PC3 and DU145 prostate cancer cell lines. C: Percentage change in the number of colony forming units in PNT2 prostate cell lines. (* <0.005; **p <0.05). D: Effect of altering FRS2 and FRS3 levels on PARP cleavage in PC3 cells. siFRS2/3- siRNA against FRS2 and FRS3 Back to article page